A peer-reviewed journal that offers evidence-based clinical information and continuing education for dentists.

FDA Provides Emergency Authorization to Fast and Inexpensive COVID-19 Test


The United States Food and Drug Administration (FDA) has granted Abbott Laboratories emergency authorization for its $5, 15-minute COVID-19 test. The antigen test is point-of-care, meaning that no lab or equipment is needed to process the test results. Tested patients will learn whether they are infected with the novel coronavirus within 15 minutes. Abbott plans on manufacturing millions of tests beginning in September with the hopes of making at least 50 million in October. Such a rapid and affordable test could make a significant difference in isolating those who are infected and slowing the rapid spread of COVID-19.  Read more here.

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy